372sek
0,9 %
Date:2026-07-20Time:18:00:00Latest report:Q1-2026List:First NorthTicker:NANEXA
Market Cap:712 msekEnterprise Value:640 msekNet Sales:32,7 msekEarnings:-23,1 msekEmployees:0ISIN:SE0007074166

Ratios

10-year key figure history for Nanexa turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nanexa with index and moving average MA50 and MA200.

Stockprice:3,72
MA50:3,88
MA200:3,29
Price/MA200:13,3 %
RSI (14):48,4
Price/MA50:-4,0 %

Description

Nanexa is a drug delivery company with a proprietary platform used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The company's technology is based on encapsulating drug particles with a thin shell and creating opportunities for pharmaceutical companies to develop new products. Nanexa has collaborations with several pharmaceutical companies, mainly around the Nordic market.

Medical Equipment